Literature DB >> 8942344

Sevoflurane degradation to compound A in anaesthesia breathing systems.

D D Cunningham1, S Huang, J Webster, J Mayoral, R W Grabenkort.   

Abstract

Determination of an effective rate constant and activation energy allowed the application of steady-state theory to predict concentrations of compound A from sevoflurane concentrations, fresh gas flow rate, absorbent temperature and amount of absorbent. Studies by eight research groups were compared. Lower concentrations of compound A than predicted were observed at low flow rates, suggesting that its degradation by the absorbent is important in limiting the maximum observed concentrations in closed and low-flow breathing systems. Trial-to-trial and batch-to-batch variations in compound A concentrations were observed in model system tests of commercial and pilot-plant absorbents. Chemical modification of the absorbent with glycerol lowered concentrations of compound A, possibly by formation of a nucleophilic addition product. An ideal chemical scavenger would remain stable and non-volatile in the absorbent before irreversibly reacting with compound A to form a stable non-volatile product.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942344     DOI: 10.1093/bja/77.4.537

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

3.  Sofnolime with different water content causes different effects in two sevoflurane inhalational induction techniques with respect to the output of compound-A.

Authors:  Shu-jie Liu; Yue Li; Bo Sun; Chang-song Wang; Yu-lei Gong; Yan-mei Zhou; En-you Li
Journal:  Int J Med Sci       Date:  2012-07-25       Impact factor: 3.738

Review 4.  Sevoflurane.

Authors:  Stefan De Hert; Anneliese Moerman
Journal:  F1000Res       Date:  2015-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.